Bettina Knapp | Lab Head / Principal Scientist
Boehringer Ingelheim Pharma GmbH & Co.KG

Dr. Bettina Knapp, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach   Dr. Bettina Knapp has been an integral part of Boehringer Ingelheim's biopharmaceutical division since 2015. She initially held responsibilities across various areas, including the validation of stage III drug substances and drug products. In this role, she also represented the company during authority and customer inspections within Boehringer’s biopharmaceutical contract manufacturing. Over the past six years, Dr. Knapp has shifted her focus towards biopharmaceutical development, particularly in upstream development. Her expertise, however, also extends to downstream and analytical development. In 2022, she assumed the role of Laboratory Head in Upstream Development. Two years later, in 2024, she took on the additional role of Product Owner for the Scrum Team "Biobase". This team is responsible for an internally developed software that integrates Biological Development and Manufacturing data. This innovative software facilitates rapid, data and model-driven decision making, fostering digital innovation across the entire development process. In 2025, Dr. Knapp transitioned from the Biobase team to become one of three members of a digital portfolio team. In this role, she provides her expertise in data management within the whole Development CMC Biologicals. The overarching aim of Dr. Knapp is to harness the power of data for insightful decision-making, strategic planning, and collectively driving innovation and efficiency.